Literature DB >> 11358386

Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.

V M Richon1, X Zhou, R A Rifkind, P A Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11358386     DOI： 10.1006/bcmd.2000.0376

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  30 in total

1.  Distribution of histone deacetylases 1-11 in the rat brain.

Authors:  Ron S Broide; Jeff M Redwine; Najla Aftahi; Warren Young; Floyd E Bloom; Christopher J Winrow
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

2.  Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents.

Authors:  Hao Cheng; Zhiliang Xie; William P Jones; Xiaohui Tracey Wei; Zhongfa Liu; Dasheng Wang; Samuel K Kulp; Jiang Wang; Christopher C Coss; Ching-Shih Chen; Guido Marcucci; Ramiro Garzon; Joseph M Covey; Mitch A Phelps; Kenneth K Chan
Journal:  AAPS J       Date:  2016-03-04       Impact factor: 4.009

3.  Editorial for Cancer Virtual Issue.

Authors:  Benjamin E Blass
Journal:  ACS Med Chem Lett       Date:  2017-12-14       Impact factor: 4.345

4.  Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity.

Authors:  Mamoru Haratake; Masashi Fukunaga; Masahiro Ono; Morio Nakayama
Journal:  J Biol Inorg Chem       Date:  2005-04-02       Impact factor: 3.358

5.  The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.

Authors:  Eli C Lewis; Lykke Blaabjerg; Joachim Størling; Sif G Ronn; Paolo Mascagni; Charles A Dinarello; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2010-12-22       Impact factor: 6.354

6.  Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells.

Authors:  Yehua Gan; Jian Wang; Joseph Coselli; Xing Li Wang
Journal:  Biochem Biophys Res Commun       Date:  2007-11-09       Impact factor: 3.575

7.  Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Yun-Feng Ni; Jian Wang; Xiao-Long Yan; Feng Tian; Jin-Bo Zhao; Yun-Jie Wang; Tao Jiang
Journal:  Respir Res       Date:  2010-03-20

Review 8.  Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.

Authors:  Sheng F Cai; Chun-Wei Chen; Scott A Armstrong
Journal:  Mol Cell       Date:  2015-11-19       Impact factor: 17.970

9.  Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines.

Authors:  Mahesh Hegde; Kempegowda Mantelingu; Monica Pandey; Chottanahalli S Pavankumar; Kanchugarakoppal S Rangappa; Sathees C Raghavan
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

10.  Histone modifications: implications in renal cell carcinoma.

Authors:  Swathi Ramakrishnan; Leigh Ellis; Roberto Pili
Journal:  Epigenomics       Date:  2013-08       Impact factor: 4.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.